Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dominick J Angiolillo

Showing results (511-520 of 761) with videos related to

Pageof 77
Sort By:
Revista Espanola De Cardiologia|June 7, 2011
[Assessment of dynamic coronary plaque changes and the clinical consequences in type-II diabetic patients: a serial intracoronary ultrasound study]Pilar Jiménez-Quevedo, Nobuaki Suzuki, Cecilia Corros, et al.
Thrombosis and Haemostasis|January 13, 2011
Functional profile of the platelet P2Y₁₂ receptor signalling pathway in patients with type 2 diabetes mellitus and coronary artery diseaseMasafumi Ueno, José L Ferreiro, Salvatore D Tomasello, et al.
JACC. Cardiovascular Interventions|September 26, 2015
Impact of Escalating Loading Dose Regimens of Ticagrelor in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: Results of a Prospective Randomized Pharmacokinetic and Pharmacodynamic InvestigationFrancesco Franchi, Fabiana Rollini, Jung Rae Cho, et al.
World Neurosurgery|September 26, 2021
Severe, Intolerable Fatigue Associated with Hyperresponse to ClopidogrelDavid I Bass, Christopher C Young, Min S Park, et al.
JACC. Cardiovascular Interventions|March 18, 2014
Pharmacodynamic effects of cangrelor on platelet P2Y12 receptor-mediated signaling in prasugrel-treated patientsFabiana Rollini, Francesco Franchi, Antonio Tello-Montoliu, et al.
The American Journal of Cardiology|January 31, 2006
Intravascular ultrasound characterization of the "black hole" phenomenon after drug-eluting stent implantationMarco A Costa, Manel Sabate, Dominick J Angiolillo, et al.
Journal of the American Heart Association|March 13, 2019
Impact of Diabetes Mellitus and Chronic Kidney Disease on Cardiovascular Outcomes and Platelet P2Y<sub>12</sub> Receptor Antagonist Effects in Patients With Acute Coronary Syndromes: Insights From the PLATO TrialFrancesco Franchi, Stefan K James, Tatevik Ghukasyan Lakic, et al.
Circulation|June 29, 2011
Ticagrelor compared with clopidogrel by geographic region in the Platelet Inhibition and Patient Outcomes (PLATO) trialKenneth W Mahaffey, Daniel M Wojdyla, Kevin Carroll, et al.
Journal of the American College of Cardiology|October 23, 2012
Reduction in platelet reactivity with prasugrel 5 mg in low-body-weight patients is noninferior to prasugrel 10 mg in higher-body-weight patients: results from the FEATHER trialDavid Erlinge, Jurrien Ten Berg, David Foley, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 22, 2022
Immature Platelet Fraction Predicts Adverse Events in Patients With Acute Coronary Syndrome: the ISAR-REACT 5 Reticulated Platelet SubstudyDario Bongiovanni, Nina Schreiner, Rosanna Gosetti, et al.
Pageof 77

Showing results (511-520 of 761) with videos related to

Sort By:
Pageof 77
Revista Espanola De Cardiologia|June 7, 2011
[Assessment of dynamic coronary plaque changes and the clinical consequences in type-II diabetic patients: a serial intracoronary ultrasound study]Pilar Jiménez-Quevedo, Nobuaki Suzuki, Cecilia Corros, et al.
Thrombosis and Haemostasis|January 13, 2011
Functional profile of the platelet P2Y₁₂ receptor signalling pathway in patients with type 2 diabetes mellitus and coronary artery diseaseMasafumi Ueno, José L Ferreiro, Salvatore D Tomasello, et al.
JACC. Cardiovascular Interventions|September 26, 2015
Impact of Escalating Loading Dose Regimens of Ticagrelor in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: Results of a Prospective Randomized Pharmacokinetic and Pharmacodynamic InvestigationFrancesco Franchi, Fabiana Rollini, Jung Rae Cho, et al.
World Neurosurgery|September 26, 2021
Severe, Intolerable Fatigue Associated with Hyperresponse to ClopidogrelDavid I Bass, Christopher C Young, Min S Park, et al.
JACC. Cardiovascular Interventions|March 18, 2014
Pharmacodynamic effects of cangrelor on platelet P2Y12 receptor-mediated signaling in prasugrel-treated patientsFabiana Rollini, Francesco Franchi, Antonio Tello-Montoliu, et al.
The American Journal of Cardiology|January 31, 2006
Intravascular ultrasound characterization of the "black hole" phenomenon after drug-eluting stent implantationMarco A Costa, Manel Sabate, Dominick J Angiolillo, et al.
Journal of the American Heart Association|March 13, 2019
Impact of Diabetes Mellitus and Chronic Kidney Disease on Cardiovascular Outcomes and Platelet P2Y<sub>12</sub> Receptor Antagonist Effects in Patients With Acute Coronary Syndromes: Insights From the PLATO TrialFrancesco Franchi, Stefan K James, Tatevik Ghukasyan Lakic, et al.
Circulation|June 29, 2011
Ticagrelor compared with clopidogrel by geographic region in the Platelet Inhibition and Patient Outcomes (PLATO) trialKenneth W Mahaffey, Daniel M Wojdyla, Kevin Carroll, et al.
Journal of the American College of Cardiology|October 23, 2012
Reduction in platelet reactivity with prasugrel 5 mg in low-body-weight patients is noninferior to prasugrel 10 mg in higher-body-weight patients: results from the FEATHER trialDavid Erlinge, Jurrien Ten Berg, David Foley, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 22, 2022
Immature Platelet Fraction Predicts Adverse Events in Patients With Acute Coronary Syndrome: the ISAR-REACT 5 Reticulated Platelet SubstudyDario Bongiovanni, Nina Schreiner, Rosanna Gosetti, et al.
Pageof 77